May 8, 2020 / 12:36 PM / 20 days ago

BRIEF-Hubei Biocause Pharmaceutical Says Insurance Unit's Jan-April Premium At 17.3 Bln Yuan

May 8 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd :

* SAYS ITS INSURANCE UNIT'S PREMIUM AT 17.3 BILLION YUAN ($2.45 billion) IN JANUARY-APRIL Source text in Chinese: bit.ly/2WdzMOK Further company coverage: ($1 = 7.0749 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below